Activation of Mitogen-activated Protein (MAP) Kinase Pathway by Pervanadate, a Potent Inhibitor of Tyrosine Phosphatases
Authors:
- Zhongjia TanZTZhongjia Tan
- Curtis D. DiltzCDCurtis D. Diltz
- Min YouMYMin You
- Edmond H. FischerEFEdmond H. Fischer
Open Access
- 1 September 1996
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 271 (36) , 22251-22255
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Roles of Protein-tyrosine Phosphatases in Stat1α-mediated Cell SignalingJournal of Biological Chemistry, 1995
- Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell linesCurrent Biology, 1995
- Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signalingCell, 1995
- Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activationCell, 1995
- The ins and outs of Raf kinasesTrends in Biochemical Sciences, 1994
- Raf meets Ras: completing the framework of a signal transduction pathwayTrends in Biochemical Sciences, 1994
- Diversity in function and regulation of MAP kinase pathwaysTrends in Biochemical Sciences, 1994
- The MAP kinase cascade is essential for diverse signal transduction pathwaysTrends in Biochemical Sciences, 1993
- Orthovanadate both mimics and antagonizes the transforming growth factor β action on normal rat kidney cellsJournal of Cellular Physiology, 1993
- Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteinsCell, 1985